# Pilot Study to Define the Immune Response Following Cryoablation of Invasive Breast Cancer

> **NCT03523299** · NA · WITHDRAWN · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins**

## Conditions studied

- Invasive Ductal Carcinoma, Breast

## Interventions

- **PROCEDURE:** Cryoablation

## Key facts

- **NCT ID:** NCT03523299
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-05-22
- **Primary completion:** 2019-08-01
- **Final completion:** 2019-08-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Principal investigator wishes to revisit design and start a new study
- **Last updated:** 2019-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03523299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03523299, "Pilot Study to Define the Immune Response Following Cryoablation of Invasive Breast Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03523299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*